Evidence map›Paper›PMID 39186276›Full record

ArticleJAMA network open2024

Pregnancy-Related Factors and Breast Cancer Risk for Women Across a Range of Familial Risk.

Jasmine A McDonald, Yuyan Liao, Julia A Knight, Esther M John, Allison W Kurian, Mary Daly, Saundra S Buys, Yun Huang, Caren J Frost, Irene L Andrulis and 8 more

Abstract read
In one paragraph

Article in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Reproductive state controls transcription in the murine liver, with implications for breast cancer liver metastasis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Unveiling the Stroma: Reproductive Factors and the Tumor Microenvironment in African Breast Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Jasmine A McDonaldColumbia University Irving Medical Center, New York, New York.
Yuyan LiaoColumbia University Irving Medical Center, New York, New York.
Julia A KnightLunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Canada.
Esther M JohnStanford University School of Medicine, Stanford, California.
Allison W KurianStanford University School of Medicine, Stanford, California.
Mary DalyFox Chase Cancer Center, Philadelphia, Pennsylvania.
Saundra S BuysUniversity of Utah Health Sciences Center, Salt Lake City.
Yun HuangMinistry of Education, Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine and School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Caren J FrostCollege of Social Work, The University of Utah, Salt Lake City.
Irene L AndrulisLunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Canada.
Sarah V ColonnaUniversity of Utah Health Huntsman Cancer Institute, Salt Lake City.
Michael L FriedlanderUniversity of New South Wales, Sydney, New South Wales, Australia.
John L HopperMelbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
Wendy K ChungColumbia University Irving Medical Center, New York, New York.
Jeanine M GenkingerColumbia University Irving Medical Center, New York, New York.
Robert J MacInnisMelbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
Mary Beth TerryColumbia University Irving Medical Center, New York, New York.
Kathleen Cuningham Foundation Consortium investigators

Funding

Core-001U01CA164920 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Irene Andrulis, Sarah Violet Colonna · 2018 to 2026
$17.0M
Genes, environment and breast cancer risk: The 15 year follow-up of the Prof-SC (Diversity Supplement)R01CA159868 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HOPPER, JOHN L, TERRY, MARY BETH · 2011 to 2015
$9.0M
The Tumor Microenvironment and Lymphatic Remodeling in Postpartum Breast CancerR01CA267897 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Jasmine Alise McDonald · 2022 to 2026
$2.4M
Medical Research CouncilNCI NIH HHS R01 CA159868NCI NIH HHS R01 CA267897NCI NIH HHS U01 CA164920
6 · The paper itself

Abstract

Importance: Few studies have investigated whether the associations between pregnancy-related factors and breast cancer (BC) risk differ by underlying BC susceptibility. Evidence regarding variation in BC risk is critical to understanding BC causes and for developing effective risk-based screening guidelines. Objective: To examine the association between pregnancy-related factors and BC risk, including modification by a of BC where scores are based on age and BC family history. Design, Setting, and Participants: This cohort study included participants from the prospective Family Study Cohort (ProF-SC), which includes the 6 sites of the Breast Cancer Family Registry (US, Canada, and Australia) and the Kathleen Cuningham Foundation Consortium (Australia). Analyses were performed in a cohort of women enrolled from 1992 to 2011 without any personal history of BC who were followed up through 2017 with a median (range) follow-up of 10 (1-23) years. Data were analyzed from March 1992 to March 2017. Exposures: Parity, number of full-term pregnancies (FTP), age at first FTP, years since last FTP, and breastfeeding. Main Outcomes and Measures: BC diagnoses were obtained through self-report or report by a first-degree relative and confirmed through pathology and data linkages. Cox proportional hazards regression models estimated hazard ratios (HR) and 95% CIs for each exposure, examining modification by PARS of BC. Differences were assessed by estrogen receptor (ER) subtype. Results: The study included 17 274 women (mean [SD] age, 46.7 [15.1] years; 791 African American or Black participants [4.6%], 1399 Hispanic or Latinx participants [8.2%], and 13 790 White participants [80.7%]) with 943 prospectively ascertained BC cases. Compared with nulliparous women, BC risk was higher after a recent pregnancy for those women with higher PARS (last FTP 0-5 years HR for interaction, 1.53; 95% CI, 1.13-2.07; P for interaction < .001). Associations between other exposures were limited to ER-negative disease. ER-negative BC was positively associated with increasing PARS and increasing years since last FTP (P for interaction < .001) with higher risk for recent pregnancy vs nulliparous women (last FTP 0-5 years HR for interaction, 1.54; 95% CI, 1.03-2.31). ER-negative BC was positively associated with increasing PARS and being aged 20 years or older vs less than 20 years at first FTP (P for interaction = .002) and inversely associated with multiparity vs nulliparity (P for interaction = .01). Conclusions and Relevance: In this cohort study of women with no prior BC diagnoses, associations between pregnancy-related factors and BC risk were modified by PARS, with greater associations observed for ER-negative BC.

Indexed as

Breast NeoplasmsAdultAustraliaBreast FeedingCanadaCohort StudiesFemaleGenetic Predisposition to DiseaseHumansMiddle AgedParityPregnancyProspective StudiesRegistriesRisk FactorsUnited States

Identifiers

PMID39186276
PMCPMC13082433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.